Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Expect Adoption of HCV Testing Guidelines

June 8, 2012 8:45 AM EDT Send to a Friend
Get Alerts OSUR Hot Sheet
Price: $4.41 +0.23%

Rating Summary:
    11 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 35 | New: 23
Trade OSUR Now!
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.

Analyst, Jeffrey Frelick, said, "We reiterate our rating on OSUR as we expect adoption of the CDC’s proposed HCV testing guidelines that all 80M baby boomers know their status or get tested once for HCV...We continue to expect OSUR to experience sequential increases in OraQuick HCV test sales as its rapid HCV test gains adoption in physician offices."

For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.

Shares of OraSure Technologies closed at $10.38 yesterday, with a 52 week range of $6.29-$12.28.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments

Add Your Comment